Article Details

RedHill says oral COVID-19 therapy improved viral clearance in severely ill patients | Seeking Alpha

Retrieved on: 2022-01-13 16:29:34

Tags for this article:

Click the tags to see associated articles and topics

RedHill says oral COVID-19 therapy improved viral clearance in severely ill patients | Seeking Alpha. View article details on hiswai:

Excerpt

RedHill Biopharma (RDHL) announced that its oral COVID-19 therapy opaganib “significantly” improved viral clearance in a Phase 2/3 trial involving ...

Article found on: seekingalpha.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up